Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Role of TRPM8 Channels in Altered Cold Sensitivity of Corneal Primary Sensory Neurons Induced by Axonal Damage.

Piña R, Ugarte G, Campos M, Íñigo-Portugués A, Olivares E, Orio P, Belmonte C, Bacigalupo J, Madrid R.

J Neurosci. 2019 Oct 9;39(41):8177-8192. doi: 10.1523/JNEUROSCI.0654-19.2019. Epub 2019 Aug 30.

PMID:
31471469
2.

Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/RTOG 0526).

Brenneman RJ, Soffen E, Gay HA, Orio PF 3rd, Christodouleas JP, Baumann JC, Baumann BC.

Transl Androl Urol. 2019 Jul;8(Suppl 3):S265-S270. doi: 10.21037/tau.2019.03.14. No abstract available.

3.

Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level.

Muralidhar V, Nguyen PL, Mahal BA, Yang DD, Mouw KW, Rose BS, Beard CJ, Efstathiou JA, Martin NE, King MT, Orio PF.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):941-948. doi: 10.6004/jnccn.2018.7283.

PMID:
31390585
4.

Stereoelectroencephalography: retrospective analysis of 742 procedures in a single centre.

Cardinale F, Rizzi M, Vignati E, Cossu M, Castana L, d'Orio P, Revay M, Costanza MD, Tassi L, Mai R, Sartori I, Nobili L, Gozzo F, Pelliccia V, Mariani V, Lo Russo G, Francione S.

Brain. 2019 Sep 1;142(9):2688-2704. doi: 10.1093/brain/awz196.

PMID:
31305885
5.

Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.

Alimena S, Yang DD, Melamed A, Mahal BA, Worley MJ Jr, Feldman S, Elias KM, Orio PF, Lee LJ, King M.

Gynecol Oncol. 2019 Sep;154(3):595-601. doi: 10.1016/j.ygyno.2019.06.022. Epub 2019 Jul 7.

PMID:
31292103
6.

Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer.

Muralidhar V, Mahal BA, Butler S, Lamba N, Yang DD, Leeman J, D'Amico AV, Nguyen PL, Trinh QD, Orio PF 3rd, King MT.

J Urol. 2019 Nov;202(5):973-978. doi: 10.1097/JU.0000000000000352. Epub 2019 Oct 9.

PMID:
31144590
7.

Prognostic factors of postoperative seizure outcome in patients with temporal lobe epilepsy and normal magnetic resonance imaging.

Mariani V, Revay M, D'Orio P, Rizzi M, Pelliccia V, Nichelatti M, Bottini G, Nobili L, Tassi L, Cossu M.

J Neurol. 2019 Sep;266(9):2144-2156. doi: 10.1007/s00415-019-09394-x. Epub 2019 May 24.

PMID:
31127383
8.

Tailored multilobar disconnective epilepsy surgery in the posterior quadrant.

Rizzi M, Revay M, d'Orio P, Scarpa P, Mariani V, Pelliccia V, Della Costanza M, Zaniboni M, Castana L, Cardinale F, Lo Russo G, Cossu M.

J Neurosurg. 2019 Apr 26:1-13. doi: 10.3171/2019.1.JNS183103. [Epub ahead of print]

PMID:
31026825
9.

In Regard to Bauer-Nilsen et al.

Orio PF 3rd, Goodwin J.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1598-1599. doi: 10.1016/j.ijrobp.2018.08.006. No abstract available.

PMID:
31014792
10.

Neurophysiological Muscle Activation Scheme for Controlling Vocal Fold Models.

Manriquez R, Peterson SD, Prado P, Orio P, Galindo GE, Zanartu M.

IEEE Trans Neural Syst Rehabil Eng. 2019 May;27(5):1043-1052. doi: 10.1109/TNSRE.2019.2906030. Epub 2019 Mar 18.

PMID:
30908260
11.

A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.

King MT, Yang DD, Muralidhar V, Mahal B, Butler S, Devlin PM, Lee LJ, Mouw KW, Martin NM, D'Amico AV, Nguyen PL, Orio PF 3rd.

Brachytherapy. 2019 Mar - Apr;18(2):186-191. doi: 10.1016/j.brachy.2018.12.007. Epub 2019 Jan 10.

PMID:
30638912
12.

Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy.

King MT, Nguyen PL, Boldbaatar N, Yang DD, Muralidhar V, Tempany CM, Cormack RA, Hurwitz MD, Suh WW, Pomerantz MM, D'Amico AV, Orio PF 3rd.

Brachytherapy. 2019 Mar - Apr;18(2):198-203. doi: 10.1016/j.brachy.2018.12.001. Epub 2019 Jan 10.

PMID:
30638910
13.

Reply to Partial gland therapy for prostate cancer.

King MT, Nguyen PL, D'Amico AV, Orio PF 3rd.

Cancer. 2019 Mar 1;125(5):819-820. doi: 10.1002/cncr.31822. Epub 2018 Dec 20. No abstract available.

PMID:
30570738
14.

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.

Yang DD, Mahal BA, Muralidhar V, Martin NE, Orio PF, Mouw KW, King MT, Choueiri TK, Trinh QD, Hoffman KE, Spratt DE, Feng FY, Nguyen PL.

Eur Urol. 2019 Jan;75(1):35-41. doi: 10.1016/j.eururo.2018.08.033. Epub 2018 Oct 24.

PMID:
30554605
15.

Chaos versus noise as drivers of multistability in neural networks.

Orio P, Gatica M, Herzog R, Maidana JP, Castro S, Xu K.

Chaos. 2018 Oct;28(10):106321. doi: 10.1063/1.5043447.

PMID:
30384618
16.

Surgery in patients with childhood-onset epilepsy: analysis of complications and predictive risk factors for a severely complicated course.

d'Orio P, Rizzi M, Mariani V, Pelliccia V, Lo Russo G, Cardinale F, Nichelatti M, Nobili L, Cossu M.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):84-89. doi: 10.1136/jnnp-2018-318282. Epub 2018 Aug 12.

PMID:
30100551
17.

Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer.

King MT, Nguyen PL, Boldbaatar N, Tempany CM, Cormack RA, Beard CJ, Hurwitz MD, Suh WW, D'Amico AV, Orio PF 3rd.

Cancer. 2018 Sep 1;124(17):3528-3535. doi: 10.1002/cncr.31568. Epub 2018 Jul 5.

18.

Determining optimal eluter design by modeling physical dose enhancement in brachytherapy.

Guthier CV, D'Amico AV, King MT, Nguyen PL, Orio PF, Sridhar S, Makrigiorgos GM, Cormack RA.

Med Phys. 2018 Jun 15. doi: 10.1002/mp.13051. [Epub ahead of print]

PMID:
29905964
19.

Synchronization transition in neuronal networks composed of chaotic or non-chaotic oscillators.

Xu K, Maidana JP, Castro S, Orio P.

Sci Rep. 2018 May 30;8(1):8370. doi: 10.1038/s41598-018-26730-9.

20.

An integrate-and-fire model to generate spike trains with long-range dependence.

Richard A, Orio P, Tanré E.

J Comput Neurosci. 2018 Jun;44(3):297-312. doi: 10.1007/s10827-018-0680-1. Epub 2018 Mar 24.

PMID:
29574632
21.

Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.

Mahal BA, Yang DD, Wang NQ, Alshalalfa M, Davicioni E, Choeurng V, Schaeffer EM, Ross AE, Spratt DE, Den RB, Martin NE, Mouw KW, Orio PF 3rd, Choueiri TK, Taplin ME, Trinh QD, Feng FY, Nguyen PL.

Eur Urol. 2018 Aug;74(2):146-154. doi: 10.1016/j.eururo.2018.01.043. Epub 2018 Feb 22.

22.

Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.

King MT, Chen MH, Moran BJ, Braccioforte MH, Buzurovic I, Muralidhar V, Yang DD, Mouw KW, Devlin PM, D'Amico AV, Nguyen PL, Orio PF 3rd.

Urol Oncol. 2018 Apr;36(4):157.e15-157.e20. doi: 10.1016/j.urolonc.2017.11.022. Epub 2017 Dec 21.

PMID:
29276060
23.

Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy.

Yang DD, Muralidhar V, Mahal BA, Nguyen PL, Devlin PM, King MT, Orio PF 3rd.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):53-58. doi: 10.1016/j.ijrobp.2017.08.046. Epub 2017 Sep 9.

PMID:
29254781
24.

Travel distance and stereotactic body radiotherapy for localized prostate cancer.

Mahal BA, Chen YW, Sethi RV, Padilla OA, Yang DD, Chavez J, Muralidhar V, Hu JC, Feng FY, Hoffman KE, Martin NE, Spratt DE, Yu JB, Orio PF 3rd, Nguyen PL.

Cancer. 2018 Mar 15;124(6):1141-1149. doi: 10.1002/cncr.31190. Epub 2017 Dec 12.

25.

Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.

Yang DD, Mahal BA, Muralidhar V, Vastola ME, Boldbaatar N, Labe SA, Nezolosky MD, Orio PF 3rd, King MT, Martin NE, Mouw KW, Trinh QD, Nguyen PL.

Clin Genitourin Cancer. 2018 Jun;16(3):226-234. doi: 10.1016/j.clgc.2017.10.013. Epub 2017 Nov 9.

PMID:
29196209
26.

USim: A New Device and App for Case-Specific, Intraoperative Ultrasound Simulation and Rehearsal in Neurosurgery. A Preliminary Study.

Perin A, Prada FU, Moraldo M, Schiappacasse A, Galbiati TF, Gambatesa E, d'Orio P, Riker NI, Basso C, Santoro M, Meling TR, Schaller K, DiMeco F.

Oper Neurosurg (Hagerstown). 2018 May 1;14(5):572-578. doi: 10.1093/ons/opx144.

PMID:
29106668
27.

IKD Current in Cold Transduction and Damage-Triggered Cold Hypersensitivity.

González A, Herrera G, Ugarte G, Restrepo C, Piña R, Pertusa M, Orio P, Madrid R.

Adv Exp Med Biol. 2017;1015:265-277. doi: 10.1007/978-3-319-62817-2_14. Review.

PMID:
29080031
28.

Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer.

Yang DD, Muralidhar V, Nguyen PL, Buzurovic I, Martin NE, Mouw KW, Devlin PM, Trinh QD, Orio PF 3rd, King MT.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):904-911. doi: 10.1016/j.ijrobp.2017.07.034. Epub 2017 Jul 31.

PMID:
29063853
29.

Travel Distance as a Barrier to Receipt of Adjuvant Radiation Therapy After Radical Prostatectomy.

Yang DD, Muralidhar V, Mahal BA, Beard CJ, Mouw KW, Martin NE, Orio PF 3rd, King MT, Nguyen PL.

Am J Clin Oncol. 2018 Oct;41(10):953-959. doi: 10.1097/COC.0000000000000410.

PMID:
29045266
30.

Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer.

Yang DD, Mahal BA, Muralidhar V, Boldbaatar N, Labe SA, Nezolosky MD, Vastola ME, Beard CJ, Martin NE, Mouw KW, Orio PF 3rd, King MT, Nguyen PL.

Cancer. 2017 Dec 15;123(24):4832-4840. doi: 10.1002/cncr.30948. Epub 2017 Aug 22.

31.

Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.

Yang DD, Mahal BA, Muralidhar V, Nezolosky MD, Vastola ME, Labe SA, Boldbaatar N, King MT, Martin NE, Orio PF 3rd, Beard CJ, Hoffman KE, Trinh QD, Spratt DE, Feng FY, Nguyen PL.

Eur Urol Focus. 2019 Jan;5(1):69-76. doi: 10.1016/j.euf.2017.05.011. Epub 2017 Jun 17.

PMID:
28753811
32.

A novel approach to an automated needle insertion in brachytherapy procedures.

Buzurovic IM, Salinic S, Orio PF, Nguyen PL, Cormack RA.

Med Biol Eng Comput. 2018 Feb;56(2):273-287. doi: 10.1007/s11517-017-1686-y. Epub 2017 Jul 15.

PMID:
28712013
33.

Epilepsy surgery in patients older than 50 years: Effectiveness, safety, and predictors of outcome.

d' Orio P, Pelliccia V, Gozzo F, Cardinale F, Castana L, Lo Russo G, Bottini G, Scarpa P, Cossu M.

Seizure. 2017 Aug;50:60-66. doi: 10.1016/j.seizure.2017.06.003. Epub 2017 Jun 10.

34.

Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.

Yang DD, Muralidhar V, Mahal BA, Nezolosky MD, Labe SA, Vastola ME, Boldbaatar N, King MT, Martin NE, Orio PF 3rd, Choueiri TK, Trinh QD, Den RB, Spratt DE, Hoffman KE, Feng FY, Nguyen PL.

Urol Oncol. 2017 Sep;35(9):542.e25-542.e32. doi: 10.1016/j.urolonc.2017.04.018. Epub 2017 May 19.

PMID:
28533151
35.

A new tool for touch-free patient registration for robot-assisted intracranial surgery: application accuracy from a phantom study and a retrospective surgical series.

Cardinale F, Rizzi M, d'Orio P, Casaceli G, Arnulfo G, Narizzano M, Scorza D, De Momi E, Nichelatti M, Redaelli D, Sberna M, Moscato A, Castana L.

Neurosurg Focus. 2017 May;42(5):E8. doi: 10.3171/2017.2.FOCUS16539.

PMID:
28463615
36.

National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.

Yang DD, Muralidhar V, Mahal BA, Labe SA, Nezolosky MD, Vastola ME, King MT, Martin NE, Orio PF 3rd, Choueiri TK, Trinh QD, Spratt DE, Hoffman KE, Feng FY, Nguyen PL.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):338-343. doi: 10.1016/j.ijrobp.2017.02.020. Epub 2017 Feb 21.

PMID:
28463152
37.

Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer.

Muralidhar V, Mahal BA, Rose BS, Chen YW, Nezolosky MD, Efstathiou JA, Beard CJ, Martin NE, Orio PF 3rd, Trinh QD, Choueiri TK, Sweeney CJ, Nguyen PL.

Clin Genitourin Cancer. 2017 Oct;15(5):563-569.e3. doi: 10.1016/j.clgc.2016.10.011. Epub 2016 Oct 28.

PMID:
28462857
38.

Stereo-EEG-guided radiofrequency thermocoagulations.

Cossu M, Cardinale F, Casaceli G, Castana L, Consales A, D'Orio P, Lo Russo G.

Epilepsia. 2017 Apr;58 Suppl 1:66-72. doi: 10.1111/epi.13687. Review.

39.

Hyperpolarization-Activated Current Induces Period-Doubling Cascades and Chaos in a Cold Thermoreceptor Model.

Xu K, Maidana JP, Caviedes M, Quero D, Aguirre P, Orio P.

Front Comput Neurosci. 2017 Mar 10;11:12. doi: 10.3389/fncom.2017.00012. eCollection 2017.

40.

Implementing patient-reported outcome surveys as part of routine care: lessons from an academic radiation oncology department.

Rotenstein LS, Agarwal A, O'Neil K, Kelly A, Keaty M, Whitehouse C, Kalinowski B, Orio PF 3rd, Wagle N, Martin NE.

J Am Med Inform Assoc. 2017 Sep 1;24(5):964-968. doi: 10.1093/jamia/ocx009.

PMID:
28339771
41.

Defining the value of magnetic resonance imaging in prostate brachytherapy using time-driven activity-based costing.

Thaker NG, Orio PF, Potters L.

Brachytherapy. 2017 Jul - Aug;16(4):665-671. doi: 10.1016/j.brachy.2016.11.013. Epub 2017 Feb 8.

PMID:
28187994
42.

Role of the Excitability Brake Potassium Current IKD in Cold Allodynia Induced by Chronic Peripheral Nerve Injury.

González A, Ugarte G, Restrepo C, Herrera G, Piña R, Gómez-Sánchez JA, Pertusa M, Orio P, Madrid R.

J Neurosci. 2017 Mar 22;37(12):3109-3126. doi: 10.1523/JNEUROSCI.3553-16.2017. Epub 2017 Feb 8.

43.

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer.

Nguyen PL, Martin NE, Choeurng V, Palmer-Aronsten B, Kolisnik T, Beard CJ, Orio PF, Nezolosky MD, Chen YW, Shin H, Davicioni E, Feng FY.

Prostate Cancer Prostatic Dis. 2017 Jun;20(2):186-192. doi: 10.1038/pcan.2016.58. Epub 2017 Jan 24.

44.

The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.

Bittner NH, Orio PF 3rd, Merrick GS, Prestidge BR, Hartford AC, Rosenthal SA.

Brachytherapy. 2017 Jan - Feb;16(1):59-67. doi: 10.1016/j.brachy.2016.06.003.

PMID:
28109632
45.

Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency Training.

Orio PF 3rd, Nguyen PL, Buzurovic I, Cail DW, Chen YW.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):624-8. doi: 10.1016/j.ijrobp.2016.07.013. Epub 2016 Jul 25.

PMID:
27681758
46.

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

Chen YW, Muralidhar V, Mahal BA, Nezolosky MD, Beard CJ, Choueiri TK, Hoffman KE, Martin NE, Orio PF, Sweeney CJ, Feng FY, Trinh QD, Nguyen PL.

Brachytherapy. 2016 Nov - Dec;15(6):695-700. doi: 10.1016/j.brachy.2016.07.001. Epub 2016 Aug 12.

PMID:
27528590
47.

The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness.

Orio PF 3rd, Nguyen PL, Buzurovic I, Cail DW, Chen YW.

Brachytherapy. 2016 Nov - Dec;15(6):701-706. doi: 10.1016/j.brachy.2016.05.001. Epub 2016 Jun 14.

PMID:
27317191
48.

Neutron radiation therapy for advanced thyroid cancers.

Chapman TR, Laramore GE, Bowen SR, Orio PF 3rd.

Adv Radiat Oncol. 2016 May 25;1(3):148-156. doi: 10.1016/j.adro.2016.05.001. eCollection 2016 Jul-Sep.

49.

Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer.

Muralidhar V, Xiang M, Orio PF 3rd, Martin NE, Beard CJ, Feng FY, Hoffman KE, Nguyen PL.

J Contemp Brachytherapy. 2016 Feb;8(1):1-6. doi: 10.5114/jcb.2016.58080. Epub 2016 Feb 29.

50.

Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.

Chen YW, Mahal BA, Muralidhar V, Nezolosky M, Beard CJ, Den RB, Feng FY, Hoffman KE, Martin NE, Orio PF, Nguyen PL.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):683-90. doi: 10.1016/j.ijrobp.2015.12.008. Epub 2015 Dec 14.

Supplemental Content

Support Center